Merck & Co. Inc. buy BMO Capital Markets
Start price
27.10.23
/
50%
€101.00
Target price
27.10.24
€125.02
Performance (%)
-4.06%
End price
28.10.24
€96.90
Summary
This prediction ended on 28.10.24 with a price of €96.90. With a performance of -4.06%, the BUY prediction by BMO_Capital_Markets finished with a loss. BMO_Capital_Markets has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.82 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -1.523% | -1.523% | 61.188% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $132.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€85.40
18.12.25
18.12.25
€110.75
18.12.26
18.12.26
30.23%
07.08.26
07.08.26
Stopped prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€108.80
13.07.26
13.07.26
€124.61
13.07.27
13.07.27
2.22%
07.08.26
07.08.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.50
01.11.24
01.11.24
€125.35
01.11.25
01.11.25
-20.95%
02.11.25
02.11.25